PharmaCielo Ltd. (PCLO.V)
CAD 0.09
(-10.0%)
CAD 0.09
(-10.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 18.24 Million CAD | 46.98% |
| 2022 | 12.41 Million CAD | 301.53% |
| 2021 | 3.09 Million CAD | 170.48% |
| 2020 | -4.38 Million CAD | 63.75% |
| 2019 | -12.1 Million CAD | -5711.82% |
| 2018 | -208.21 Thousand CAD | -139.08% |
| 2017 | -87.08 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 19.06 Million CAD | 4.51% |
| 2024 Q2 | 20.1 Million CAD | 5.42% |
| 2023 Q3 | 16.77 Million CAD | 9.88% |
| 2023 Q4 | 18.24 Million CAD | 8.78% |
| 2023 FY | 18.24 Million CAD | 46.98% |
| 2023 Q1 | 13.82 Million CAD | 11.33% |
| 2023 Q2 | 15.26 Million CAD | 10.46% |
| 2022 FY | 12.41 Million CAD | 301.53% |
| 2022 Q2 | 8.95 Million CAD | 34.93% |
| 2022 Q1 | 6.63 Million CAD | 114.75% |
| 2022 Q4 | 12.41 Million CAD | 10.9% |
| 2022 Q3 | 11.19 Million CAD | 24.95% |
| 2021 Q1 | 228.67 Thousand CAD | 105.21% |
| 2021 FY | 3.09 Million CAD | 170.48% |
| 2021 Q4 | 3.09 Million CAD | 259.7% |
| 2021 Q3 | -1.93 Million CAD | 72.31% |
| 2021 Q2 | -6.99 Million CAD | -3157.07% |
| 2020 Q2 | -3.6 Million CAD | 20.55% |
| 2020 Q4 | -4.38 Million CAD | -139.72% |
| 2020 FY | -4.38 Million CAD | 63.75% |
| 2020 Q1 | -4.54 Million CAD | 62.46% |
| 2020 Q3 | -1.82 Million CAD | 49.29% |
| 2019 Q3 | -3.08 Million CAD | 80.25% |
| 2019 Q2 | -15.59 Million CAD | 32.56% |
| 2019 Q1 | -23.12 Million CAD | -11468.35% |
| 2019 FY | -12.1 Million CAD | -5711.82% |
| 2019 Q4 | -12.1 Million CAD | -292.8% |
| 2018 Q3 | -208.21 Thousand CAD | 18.06% |
| 2018 Q1 | -286.75 Thousand CAD | -255.86% |
| 2018 Q2 | -254.1 Thousand CAD | 11.39% |
| 2018 Q4 | -199.93 Thousand CAD | 3.97% |
| 2018 FY | -208.21 Thousand CAD | -139.08% |
| 2017 Q4 | -80.58 Thousand CAD | 0.0% |
| 2017 FY | -87.08 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 4.89 Million CAD | -272.866% |
| CanadaBis Capital Inc. | 4.08 Million CAD | -346.767% |
| Decibel Cannabis Company Inc. | 37.48 Million CAD | 51.321% |
| Delivra Health Brands Inc. | -2.17 Million CAD | 939.691% |
| Entourage Health Corp. | 150.32 Million CAD | 87.862% |
| Lifeist Wellness Inc. | -188.12 Thousand CAD | 9798.926% |
| Cannara Biotech Inc. | 41.51 Million CAD | 56.046% |
| Medicure Inc. | -5.82 Million CAD | 413.245% |
| Rubicon Organics Inc. | 475.37 Thousand CAD | -3738.361% |
| BioSyent Inc. | -3.68 Million CAD | 595.16% |
| Voyageur Pharmaceuticals Ltd. | 37.91 Thousand CAD | -48024.734% |